Navigation Links
It Is Possible To Detect Alzheimer's Early,,

The latest issue of the Harvard Mental Health Letter had published a report on a new way to detect Alzheimer’s’ disease in the early stages.

According to the Harvard Mental Health Letter, tests of // cognitive function are the best way so far to predict whether healthy elderly people will develop Alzheimer’s. In one study, more than 80% of people who scored below a certain level on a test of delayed word recall developed Alzheimer’s over the next 10 years. Brain scans may also prove useful. Research suggests that they are now almost as accurate as psychological tests in predicting the course of the illness.

Researchers are working on ways to detect small changes in beta-amyloid and tau protein—biological markers for the disease—in blood and spinal fluid. They're also making progress in determining the genetic markers for Alzheimer’s.

Even though there is currently no treatment or cure for Alzheimer’s, early detection is valuable. It affords people the opportunity to decide on long-term care and other important legal and family matters before the disease sets in. Individuals are more likely to address other risk factors for dementia (such as vascular problems) if they learn of their risk of the disease. Researchers will be able to conduct more and better clinical trials on the subject, an important step toward developing effective treatments.

Source: Nwswise
'"/>




Page: 1

Related medicine news :

1. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
2. Possible benefits of Hormone Replacement Therapy
3. Low Protein Levels A Possible Indicator For A Miscarriage
4. Cure For Persistent Oral Fungal Problem May Be Possible
5. Transfer Of Rabies Virus Possible From Organ Donor To Recipient
6. Possible location of lung cancer genes found
7. Treatment May Be Possible For Degenerative Brain And Spinal Cord Disease
8. Its Possible To Grow Bone To Replace The Damaged Bone
9. Healthy At 50: Possible?
10. Outpatient Treatment Possible For Patients with Uterine Fibroid Tumors
11. Safe Driving Is Possible For Older People If They Are Prepared
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Possible Detect Alzheimer Early

(Date:12/4/2009)ANAHEIM, Calif., Dec. 4 Pamela Bowen, Chief Information Officer at Crescent Healthcare, was selected as a finalist for the "Chief Innovation Officer" Appy Award for transforming Crescent,s business w
(Date:12/4/2009)WASHINGTON, Dec. 4 In response to the U.S. Justice Department Drug Enforcement Agency,s (DEA) classification of boldione, desoxymethyltestosterone, and 19-nor-4,9(10)-androstadienedione as "anabolic
(Date:12/4/2009)STANFORD, Calif. A new study shows that muscle cells grown in the lab can restore an intestine,s ability to squeeze shut properly. The work, performed in dogs and rats, might ultimately help treat pa
(Date:12/4/2009)Case Western Reserve University researchers, from the School of Medicine,s Department of Nutrition, discovered two new metabolic pathways by which products of lipid peroxidation and some drugs of abus
(Date:12/4/2009)Rockville, MD "Why is it that men can be bastards and women must wear pearls and smile?" wrote author Lynn Hecht Schafran. The answer, according to an article in the Journal of Vision , may lie in
Breaking Medicine News(10 mins):Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2Health News:Natural Products Association Issues Statement on DEA's Steroid Classification Action 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 3Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 4Health News:Case Western Reserve researchers' new pathway discovery published as 'Paper of the Week' 2Health News:Are angry women more like men? 2
... Houston-based Law Firm Offers Assistance...bri Effects. , Houston, T...awyers Pulaski & Middleman announce the launch...abri (natalizumab)., , ,Tysabri, a drug used to tr...
...1 The federal Centers for,Disease Control and Pre...of,annual new cases of HIV infections will be reve... of the American Medical Association (JAMA). The,r... revised estimate for 2006 will replace the curren...
...th glioblastoma multiforme (GBM), one of the most ... poor prognosis. Although pre-clinical studies ind... known as receptor tyrosine kinases (RTKs) would l...to such treatment and most subsequently relapse af...
..."convenience to home or work" as the main reason t... recent study conducted by researchers at the Univ...t Center in Cincinnati, OH. , The study included...y C. Mahoney, MD, lead author of the study. , Th...
...g. 1 Veridex, LLC announced today it,has complete...ially all of,the assets of Immunicon Corporation (...sidiaries., The assets acquired include intellect...ate the detection and enumeration,of circulating t...
...PRNewswire-FirstCall/ - Transition Therapeutics In... TSX:TTH) reports today that,there are no undisclo...olving the Company to account for its recent chang...ions with large markets. Transition,s lead,product...
Other Medicine News:Health News:Tysabri Lawyers Pulaski & Middleman Launch Web Resource Center for Patients Suffering from Tysabri Side Effects 2Health News:Estimate of Annual HIV Incidence Increases Significantly; New Estimate Will Show Need For a National AIDS Strategy 2Health News:Estimate of Annual HIV Incidence Increases Significantly; New Estimate Will Show Need For a National AIDS Strategy 3Health News:Transition Therapeutics Announces No Material Change 2
(Date:12/3/2009)WILMINGTON, Del., Dec. 3 ParagonRx, a Delaware-based company specializing in pharmaceutical risk management and optimal medication use, will host a free webinar on Wednesday, Dec. 9, on the FDA,s dra
(Date:12/3/2009)FORT WORTH, Texas, Dec. 3 Wound Management Technologies, Inc. (OTC Bulletin Board: WNDM), a rapidly growing provider of specialty medical products, announced today an agreement with the Health In
(Date:12/3/2009)COSTA MESA, Calif., Dec. 3 TROY Group, Inc., a Worldwide Leader in Secure on-Demand Printing Solutions, announces the addition of the TROY 3015 SecureRx(TM) Printer to its line of secure prescripti
Breaking Medicine Technology:Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 2Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 3New TROY SecureRx Prescription Printer Marks 50th Hospital Installation Milestone 2MediciGlobal Wins Four International 2009 Communications Awards for Patient Recruitment and Retention 49256 1MediciGlobal Wins Four International 2009 Communications Awards for Patient Recruitment and Retention 49256 2Texas Institute for Surgery at Presbyterian Hospital of Dallas Introduces the First Wireless OR in DFW 49253 1Texas Institute for Surgery at Presbyterian Hospital of Dallas Introduces the First Wireless OR in DFW 49253 2National Minority Quality Forum to Release Groundbreaking National HIV AIDS Atlas 49249 1National Minority Quality Forum to Release Groundbreaking National HIV AIDS Atlas 49249 2
...nt Infusion Study in Patients with,Chronic Decompe...lege of Cardiology 56th Annual Scientific Session ...5, 2007,/PRNewswire/ -- Scios Inc. announced today...f nesiritide (NATRECOR(R)) showed a,neutral effect...,cardiorenal hospitalization at 12 weeks, and prov...
... Technology Holds Promise as,Future-Generation Tre...h Coronary Artery Disease, ABBOTT PARK, Ill., Marc...announced positive results from ABSORB, the world,...ty and performance,of a fully bioabsorbable drug- ...ry artery disease. Six- month results from the,fir...
Other Medicine Technology:Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 2Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 3Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 4Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 5Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 6Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 7Abbott Announces Positive Six-Month Results From the World's First,Clinical Trial of a Fully Bioabsorbable Drug-Eluting Coronary Stent 2Abbott Announces Positive Six-Month Results From the World's First,Clinical Trial of a Fully Bioabsorbable Drug-Eluting Coronary Stent 3
Lap Disc Hand Access Device
SleepStyle 232
ResMed S7™ Lightweight CPAP Device
REMstar Pro with C-Flex
Medicine Products: